New hope for cancer pain: experimental drug aims to ease suffering
Symptom relief
Not yet recruiting
This study tests whether a new drug called 3D1002, used alone or with a standard painkiller (oxycodone), can better control moderate to severe pain in people with cancer. About 177 adults with confirmed cancer and stable pain will take part. The goal is to see if the combination …
Phase: PHASE2 • Sponsor: 3D Medicines • Aim: Symptom relief
Last updated May 17, 2026 10:39 UTC